Skip to main content

Table 3 Imbalance of patient characteristics before and after propensity score matching in the assessment of 30-day mortality

From: Association between statin use on delirium and 30-day mortality in patients with chronic obstructive pulmonary disease in the intensive care unit

Item

n

Unmatched

SMD

Matched

SMD

Non-statins

Statins

SMD

− 0.1

Non-statins

Statins

SMD

− 0.1

1241

1484

  

882

882

  

Age (year)

69.46 (11.77)

73.12 (9.80)

0.338

> 0.1

71.83 (11.33)

71.76 (9.87)

0.006

< 0.1

SBP (mmHg)

116.61 (15.63)

117.41 (16.35)

0.05

< 0.1

117.40 (15.67)

117.50 (16.32)

0.006

< 0.1

DBP(mmHg)

63.14 (10.99)

60.91 (10.59)

0.207

> 0.1

62.43 (10.97)

62.24 (10.85)

0.017

< 0.1

HR (beats/min)

87.74 (16.36)

84.37 (14.75)

0.216

> 0.1

86.25 (16.04)

85.81 (15.29)

0.028

< 0.1

RR (beats/min)

19.91 (3.87)

19.76 (3.48)

0.041

< 0.1

19.75 (3.67)

19.90 (3.54)

0.042

< 0.1

SpO2 (%)

96.16 (2.34)

96.18 (2.20)

0.008

< 0.1

96.18 (2.20)

96.15 (2.18)

0.013

< 0.1

CHF

422 (34.0)

794 (53.5)

0.401

> 0.1

374 (42.4)

377 (42.7)

0.007

< 0.1

Asthma

55 ( 4.4)

59 ( 4.0)

0.023

< 0.1

36 ( 4.1)

46 (5.2)

0.054

< 0.1

Diabetes

315 (25.4)

623 (42.0)

0.357

> 0.1

273 (31.0)

281 (31.9)

0.02

< 0.1

Liver disease

219 (17.6)

95 ( 6.4)

0.351

> 0.1

74 ( 8.4)

86 (9.8)

0.047

< 0.1

Renal disease

215 (17.3)

477 (32.1)

0.349

> 0.1

193 (21.9)

190 (21.5)

0.008

< 0.1

Malignant cancer

255 (20.5)

191 (12.9)

0.207

> 0.1

158 (17.9)

143 (16.2)

0.045

< 0.1

HGB(g/L)

11.46 (2.26)

11.26 (2.10)

0.094

< 0.1

11.37 (2.21)

11.47 (2.14)

0.046

 < 0.1

WBC(10^9/L)

15.01 (14.11)

14.51 (7.95)

0.043

< 0.1

14.74 (10.07)

15.03 (8.22)

0.032

< 0.1

Glucose (mg/dl)

169.56 (96.72)

177.37 (104.89)

0.077

< 0.1

170.17 (100.76)

172.59 (99.14)

0.024

< 0.1

Sodium (mmol/L)

139.55 (5.27)

139.73 (4.64)

0.036

< 0.1

139.64 (5.04)

139.64 (4.51)

< 0.001

< 0.1

Potassium (mmol/L)

4.68 (0.90)

4.70 (0.83)

0.023

< 0.1

4.67 (0.89)

4.69 (0.80)

0.017

< 0.1

Anion gap (mmol/L)

16.50 (4.65)

16.26 (4.35)

0.054

< 0.1

16.16 (4.29)

16.22 (4.35)

0.014

< 0.1

Glucocorticoid

483 (38.9)

485 (32.7)

0.13

> 0.1

330 (37.4)

321 (36.4)

0.021

< 0.1

Antibiotic

1073 (86.5)

1207 (81.3)

0.14

> 0.1

741 (84.0)

742 (84.1)

0.003

< 0.1

Vasopressin

114 (9.2)

170 (11.5)

0.075

< 0.1

89 (10.1)

82 (9.3)

0.027

< 0.1

Epinephrine

56 (4.5)

74 (5.0)

0.022

< 0.1

44 (5.0)

43 (4.9)

0.005

< 0.1

Norepinephrine

238 (19.2)

337 (22.7)

0.087

< 0.1

181 (20.5)

171 (19.4)

0.028

< 0.1

ACEI.ARB

122 (9.8)

294 (19.8)

0.284

> 0.1

109 (12.4)

119 (13.5)

0.034

< 0.1

β-blocker

545 (43.9)

892 (60.1)

0.328

> 0.1

462 (52.4)

464 (52.6)

0.005

< 0.1

CCI

6.98 (2.62)

7.82 (2.47)

0.33

> 0.1

7.28 (2.65)

7.28 (2.47)

< 0.001

< 0.1

SAPII

40.39 (14.03)

39.28 (11.58)

0.087

< 0.1

39.57 (12.52)

39.78 (12.46)

0.017

< 0.1

OASIS

35.51 (9.39)

33.29 (8.46)

0.249

> 0.1

34.46 (8.84)

34.48 (8.79)

0.002

< 0.1

Los-ICU

6.01 (6.45)

5.10 (5.45)

0.152

> 0.1

5.48 (5.85)

5.42 (5.69)

0.01

< 0.1

  1. An absolute MSD < 10% was considered to support the assumption of a balance between the groups. SMD: standardized mean differences. Data are presented as medians [interquartile ranges], mean [SD] or as numbers (percentages)
  2. SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, RR respiratory rate, HGB hemoglobin, WB white blood cell count, ACEI/ARB angiotensin-converting enzyme inhibitors/angiotensin II inhibitors, CCI Charlson comorbidity index, SAPS II Simplified Acute Physiology Score, OASIS Oxford Acute Severity of Illness Score, Los length of stay